Application 020918
- Type
- NDA
- Sponsor
- NOVO NORDISK
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GLUCAGEN | GLUCAGON HYDROCHLORIDE | INJECTABLE;INJECTION | EQ 1MG BASE/VIAL | Yes | Yes |
| 002 | GLUCAGEN | GLUCAGON HYDROCHLORIDE | POWDER;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | EQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Yes | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0169-7065 | GlucaGen HypoKit | glucagon hydrochloride | Novo Nordisk | NDA | Current |
| 0169-7065 | GlucaGen HypoKit | glucagon hydrochloride | Novo Nordisk | NDA | Current |
| 0169-7065 | GlucaGen HypoKit | glucagon hydrochloride | Novo Nordisk | NDA | Current |
| 0169-7065 | GlucaGen HypoKit | glucagon hydrochloride | Novo Nordisk | NDA | Current |
| 0169-7065 | GlucaGen HypoKit | glucagon hydrochloride | Novo Nordisk | NDA | Current |
| 0597-0053 | GlucaGen | glucagon hydrochloride | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0053 | GlucaGen | glucagon hydrochloride | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0053 | GlucaGen | glucagon hydrochloride | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0053 | GlucaGen | glucagon hydrochloride | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0053 | GlucaGen | glucagon hydrochloride | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0260 | GlucaGen | glucagon hydrochloride | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0260 | GlucaGen | glucagon hydrochloride | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0260 | GlucaGen | glucagon hydrochloride | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0260 | GlucaGen | glucagon hydrochloride | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0260 | GlucaGen | glucagon hydrochloride | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 68169 | SUPPL | 2021-07-23 |
| 68144 | SUPPL | 2021-07-22 |
| 66764 | SUPPL | 2021-03-12 |
| 66761 | SUPPL | 2021-03-12 |
| 64589 | SUPPL | 2020-09-17 |
| 54866 | SUPPL | 2018-07-09 |
| 53763 | SUPPL | 2018-04-20 |
| 53737 | SUPPL | 2018-04-19 |
| 13735 | SUPPL | 2015-12-15 |
| 3746 | SUPPL | 2015-12-15 |
| 3745 | SUPPL | 2014-03-19 |
| 3744 | SUPPL | 2013-04-30 |
| 26190 | SUPPL | 2012-01-17 |
| 13734 | SUPPL | 2012-01-06 |
| 35640 | SUPPL | 2010-12-22 |
| 3743 | SUPPL | 2010-12-21 |
| 41811 | SUPPL | 2007-07-20 |
| 41810 | SUPPL | 2007-07-20 |
| 35639 | SUPPL | 2005-11-18 |
| 26189 | SUPPL | 2005-11-18 |
| 41809 | ORIG | 2005-06-23 |
| 13733 | SUPPL | 2004-12-29 |
| 3742 | SUPPL | 2004-12-29 |
| 35638 | SUPPL | 2004-04-05 |
| 26188 | SUPPL | 2004-03-02 |
| 3741 | SUPPL | 2002-07-11 |
| 26187 | ORIG | 1998-06-22 |
| 13732 | ORIG | 1998-06-22 |